Ensayos clínicos de Melanoma en Ohio
40 estudios sobre Melanoma buscan participantes en Ohio.
Ciudades en Ohio
- Columbus21 estudios
- Cincinnati17 estudios
- Cleveland13 estudios
- Akron8 estudios
- Toledo8 estudios
- Dayton7 estudios
- Youngstown3 estudios
- Newark3 estudios
- Findlay3 estudios
- Parma3 estudios
Texto oficial del estudio (inglés)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Oncology Hematology Care Clinical Trials, Cincinnati
- Seidman Cancer Center, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06246916BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Miami Valley Hospital South, Centerville
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05136196DESTINY-PANTUMOUR04
- Research Site, Canton
- Research Site, Maumee
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
ReclutandoFase 2
Hasta los 25 · Todos los sexos · Actualizado el 24 sept 2026 · NCT07621614Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Oncology Hematology Care, Cincinnati
- Ohio State University, Columbus
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT05727904Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Good Samaritan Hospital - Cincinnati, Cincinnati
- y 5 más
ReclutandoFase 3
Edades de 75 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07068074Pan-tumor MRD Study
- Gabrail Cancer Center, Canton
- Taylor Cancer Research Center, Maumee
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06605404Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- Ohio State University, Columbus
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT06529822A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Indu and Raj Soin Medical Center, Beavercreek
- Strecker Cancer Center-Belpre, Belpre
- y 56 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cleveland Clinic, Cleveland
- Toledo Clinic Cancer Center, Toledo
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT05059444Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Cincinnati Medical Center, Cincinnati
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07287917Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton
- y 44 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Cleveland Clinic Taussig Cancer Center, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07070232A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Cleveland Clinic, Cleveland
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT04913285Project: Every Child for Younger Patients With Cancer
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- y 5 más
ReclutandoEstudio observacional
Hasta los 25 · Todos los sexos · Actualizado el 25 ago 2026 · NCT02402244Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT04851119Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
- University of Cincinnati Cancer Center, Cincinnati
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 ago 2026 · NCT06425926A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT05592626Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1
Edades de 18 a 99 · Todos los sexos · Actualizado el 13 jul 2026 · NCT04697576Integrated Cancer Repository for Cancer Research
- Aultman Alliance Community Hospital, Alliance
- Aultman Hospital, Canton
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- University of Cincinnati, Cincinnati
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 11 jun 2026 · NCT05361174Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 jun 2026 · NCT05588453Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- University of Cincinnati Cancer Center, Cincinnati
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jun 2026 · NCT03947385Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Christ Hospital Cancer Center, Cincinnati
- Taylor Cancer Research Center, Maumee
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 may 2026 · NCT05379985ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 may 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Cole Eye Institute-9500 Euclid Ave, Cleveland
- Ohio State Eye and Ear Institute, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- The Ohio State University, Columbus
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 abr 2026 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Indu and Raj Soin Medical Center, Beavercreek
- Strecker Cancer Center-Belpre, Belpre
- Dayton Physician LLC - Englewood, Dayton
- y 9 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 2
Edades de 18 a 99 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06223659Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- The Ohio State University Wexner Medical Center, Columbus
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 9 mar 2026 · NCT04792463Promoting Immunotherapy Efficacy With Low-Dose Liver RT
- University of Cincinnati Medical Center, Cincinnati
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT07225036Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 feb 2026 · NCT05549297A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 17 feb 2026 · NCT04567706Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 dic 2025 · NCT03567889A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 138, Canton
- Research Site 113, Cincinnati
- Research Site 131, Dayton
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 nov 2025 · NCT05914116Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- Cleveland Clinic, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT06249048SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Cincinnati
- Massive Bio SYNERGY-AI site, Columbus
- Massive Bio SYNERGY-AI site, Mayfield Heights
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
- Gabrail Cancer Center Research, Canton
- Cleveland Clinic, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 may 2025 · NCT05970497Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University Hospitals Avon Health Center, Avon
- Miami Valley Hospital South, Centerville
- University Hospitals Geauga Medical Center, Chardon
- y 6 más
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 nov 2024 · NCT03860883A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Cleveland Clinic, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 nov 2024 · NCT05824975De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.